New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...
To address these shortcomings, we introduce SymPcNSGA-Testing (Symbolic execution, Path clustering and NSGA-II Testing), a ...
A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...
Worried that your latest ask to a cloud-based AI reveals a bit too much about you? Want to know your genetic risk of disease without revealing it to the services that compute the answer? There is a ...
Funding will expand the range of Dualase(R) genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a ...
An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...
In most boardrooms, the final decision still comes down to a small circle of leaders weighing a narrow set of choices. Yet ...
Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat the untreatable, today announced that together with Western ...
Interesting Engineering on MSN
Noise-powered design uses heat for computing, can beat classical system’s power efficiency
Researchers at the Lawrence Berkeley National Laboratory have developed a design and training framework ...
In the study The Shadow and the Self in Digital Twins in Healthcare as an AI Environment, published in AI & Society, researchers explore how digital twins may influence not only medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results